【レポートの概要(一部)】
1. Report Overview
1.1 Global Ophthalmic Drugs Market Overview
1.2 Global Ophthalmic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Ophthalmic Drugs
2.1 The Pharmaceutical Industry: a Very Brief Overview
2.2 The Global Burden of Eye Disease
2.3 Ophthalmic Drugs: Market Segmentation
2.4 Glaucoma: the ‘Silent Thief of Sight’
2.4.1 A Classification of Glaucoma
2.4.1.1 Primary Open-Angle Glaucoma
2.4.1.2 Acute Angle-Closure Glaucoma
2.4.1.3 Congenital Glaucoma
2.4.1.4 Secondary Glaucoma
2.4.1.5 Normal-Tension Glaucoma
2.4.1.6 Ocular Hypertension
2.4.2 Risk Factors for Glaucoma
2.4.3 Diagnosis of Glaucoma
2.4.4 Drug Treatment of Glaucoma
2.4.5 Laser Treatment and Surgery for Glaucoma
2.5 Age-Related Macular Degeneration (AMD)
2.5.1 Dry (non-exudative) AMD
2.5.2 Wet (exudative) AMD
2.5.3 Risk Factors for AMD
2.5.4 Diagnosis of AMD
2.5.5 Treatment of AMD
2.6 Diabetic Retinopathy (DR)
2.6.1 Diagnosis of Diabetic Retinopathy
2.6.2 Treatment of Diabetic Retinopathy
2.7 Ocular Allergy and Allergic Conjunctivitis
2.7.1 Diagnosis of Ocular Allergy
2.7.2 Treatment of Ocular Allergy
2.8 Ocular Inflammatory Disease
2.8.1 Treatment of Ocular Inflammatory Disease
2.9 Eye Infections
2.9.1 Treatment of Eye Infections
2.10 Dry Eye Syndrome
2.10.1 Treatment of Dry Eye Syndrome
2.11 Phases of Clinical Trials
2.12 Currency Exchange Rates in This Report
3. Ophthalmic Drugs: World Market 2016-2026
3.1 The World Ophthalmic Drugs Market in 2015
3.2 World Ophthalmic Drugs Market: Sales Forecast 2016-2026
3.3 Leading Ophthalmic Drugs
3.4 Leading Companies in the Ophthalmic Drugs Market
3.4.1 Top 25 Ophthalmic Drug Manufacturers
3.5 Ophthalmic Drugs Market Segments: Sales Forecasts 2016-2026
3.5.1 Retinal Disorders Drugs Market: Sales Forecast 2016-2026
3.5.2 Allergic, Inflammatory and Infective Drugs Market: Sales Forecast 2016-2026
3.5.3 Glaucoma Drugs Market: Sales Forecast 2016-2026
3.5.4 Dry Eye Drugs Market: Sales Forecast 2016-2026
3.5.5 Other Ophthalmic Drugs Market: Sales Forecast 2016-2026
3.6 How Will Market Shares Change to 2026?
3.7 World Ophthalmic Drugs Market: Drivers and Restraints 2016-2026
3.7.1 World Ophthalmic Drugs Market: Analysis of Drivers
3.7.2 World Ophthalmic Drugs Market: Analysis of Restraints
4. Leading US Ophthalmic Drug Manufacturers 2016-2026
4.1 Allergan Overview
4.1.1 Allergan: Ophthalmic Product Portfolio
4.1.1.1 Restasis: Generic Launch in 2016?
4.1.1.2 Restasis: Sales Forecast 2016-2026
4.1.1.3 Lumigan and Ganfort: Marketed in Over 67 Countries
4.1.1.4 Lumigan and Ganfort: Sales Forecast 2016-2026
4.1.1.5 Refresh Brand Products: the Range
4.1.1.6 Alphagan/Alphagan P and Combigan: Extended Lifecycle
4.1.1.7 Alphagan/Alphagan P and Combigan: Sales Forecast 2016-2026
4.1.1.8 Acular: New Forms Receiving FDA Approvals
4.1.1.9 Ozurdex (Dexamethasone Intravitreal Implant): The First Drug Therapy for Diabetic Macular Edema
4.1.2 Allergan: Late Stage Ophthalmic Product Pipeline
4.1.3 Allergan: Ophthalmic Revenue Forecast 2016-2026
4.1.3.1 Allergan: Ophthalmic Drugs Market Share Forecast 2016-2026
4.1.4 Allergan: SWOT Analysis
4.2 Pfizer Overview
4.2.1 Pfizer: Ophthalmic Product Portfolio
4.2.1.1 Xalatan/Xalacom: First Ophthalmic Blockbuster
4.2.1.2 Xalatan/Xalacom: Sales Forecast 2016-2026
4.2.2 Pfizer: Ophthalmic Product Pipeline
4.2.3 Pfizer: Revenue Forecast 2016-2026
4.2.3.1 Pfizer: Ophthalmic Drugs Market Share Forecast 2016-2026
4.2.4 Pfizer: SWOT Analysis
4.3 Regeneron Overview
4.3.1 Regeneron: Ophthalmic Product Portfolio
4.3.1.1 Eylea: Superior Clinical Outcomes than Lucentis and Avastin?
4.3.1.2 Eylea: US Sales Forecast 2016-2026
4.3.2 Regeneron: Ophthalmic Product Pipeline
4.3.3 Regeneron: Revenue Forecast 2016-2026
4.3.3.1 Regeneron: Ophthalmic Drugs Market Share Forecast 2016-2026
4.3.4 FDA Approves Zaltrap (aflibercept)
4.3.5 Eylea/Zaltrap and the Davis-Smyth Patent Agreements
4.3.6 Regeneron: SWOT Analysis
4.4 Akorn Overview
4.4.1 Akorn: Ophthalmic Product Portfolio
4.4.1.1 AzaSite: AzaSite Plus and AzaSite Xtra Set to Drive AzaSite Sales
4.4.1.2 Cosopt/Cosopt PF: Acquired from Merck
4.4.2 Akorn: Revenue Forecast 2016-2026
4.4.2.1 Akorn: Ophthalmic Drugs Market Share Forecast 2016-2026
4.4.3 Akorn: SWOT Analysis
5. Leading European Ophthalmic Drug Manufacturers 2016-2026
5.1 Bayer Overview
5.1.1 Bayer: Ophthalmic Product Pipeline
5.1.2 Eylea: non-US Sales Forecast 2016-2026
5.1.3 Bayer: Revenue Forecast 2016-2026
5.1.3.1 Bayer: Ophthalmic Drugs Market Share Forecast 2016-2026
5.2 Novartis (including Alcon) Overview
5.2.1 Novartis: Ophthalmic Product Portfolio
5.2.1.1 Lucentis: Still a Leading Drug in AMD
5.2.1.2 Lucentis: Non-US Sales Forecast 2016-2026
5.2.1.3 Travatan/Travatan Z and DuoTrav: DuoTrav Awaiting US Approval
5.2.1.4 Travatan/Travatan Z and DuoTrav: Sales Forecast 2016-2026
5.2.1.5 Vigamox: Competes with Alcon’s Moxeza
5.2.1.6 Vigamox: Sales Forecast 2016-2026
5.2.1.7 Azopt: Marketed in Major Markets
5.2.1.8 Azopt: Sales Forecast 2016-2026
5.2.1.9 Jetrea: Sales Revenues Fall Short
5.2.1.10 Jetrea: Non-US Sales Forecast 2016-2026
5.2.2 Novartis: Ophthalmic Product Pipeline
5.2.2.1 Finafloxacin (MerLion Pharmaceuticals/Novartis)
5.2.2.2 AKB 9778 (Aerpio Therapeutics)
5.2.3 Novartis: Revenue Forecast 2016-2026
5.2.3.1 Novartis: Ophthalmic Drugs Market Share Forecast 2016-2026
5.2.4 Novartis: SWOT Analysis
5.3 Roche Overview
5.3.1 Roche: Ophthalmic Product Portfolio
5.3.1.1 Lucentis: US Sales Forecast 2016-2026
5.3.1.2 Avastin: Off-Label Use for Wet AMD Cannibalising Lucentis Sales
5.3.1.3 Avastin: Sales Forecast 2016-2026
5.3.2 Roche: Ophthalmic Product Pipeline
5.3.2.1 Lampalizumab (RG7417)
5.3.3 Roche: Revenue Forecast 2016-2026
5.3.3.1 Roche: Ophthalmic Drugs Market Share Forecast 2016-2026
5.3.4 Roche: SWOT Analysis
6. Leading Asia-Pacific and Other Ophthalmic Drug Manufacturers 2016-2026
6.1 Santen Overview
6.1.1 Santen: Ophthalmic Product Portfolio
6.1.1.1 Eylea: Japan Sales Forecast 2016-2026
6.1.1.2 Hyalein
6.1.1.3 Hyalein: Sales Forecast 2016-2026
6.1.1.4 Cosopt: Non-US Sales Forecast 2016-2026
6.1.1.5 Tapros/Taflotan: Sales Forecast 2016-2026
6.1.1.6 Diquas: Sales Forecast 2016-2026
6.1.1.7 Cravit: Higher Concentration Showing Significant Efficacy
6.1.1.8 Cravit: Sales Forecast 2016-2026
6.1.1.9 Alesion: Sales Forecast 2016-2026
6.1.2 Santen: Ophthalmic Product Pipeline
6.1.3 Santen: Revenue Forecast 2016-2026
6.1.3.1 Santen: Ophthalmic Drugs Market Share Forecast 2016-2026
6.1.4 Santen: SWOT Analysis
6.2 Senju Overview
6.2.1 Senju: Ophthalmic Product Portfolio
6.2.2 Senju: Ophthalmic Product Pipeline
6.2.2.1 Y 39983 (SNJ 1656)
6.2.2.2 Difluprednate (SJE-2079)
6.2.3 Senju: Revenue Forecast 2016-2026
6.2.3.1 Senju: Ophthalmic Drugs Market Share Forecast 2016-2026
6.2.4 Senju: SWOT Analysis
6.3 Valeant Overview
6.3.1 Valeant: Ophthalmic Product Portfolio
6.3.1.1 Lotemax: New Formulation Launch Expected in 2016
6.3.1.2 Lotemax: Sales Forecast 2016-2026
6.3.2 Valeant: Ophthalmic Product Pipeline
6.3.2.1 Vesneo (Latanoprostene Bunod)
6.3.2.2 Brimonidine tartarate 0.0025% for Eye Whitening (Valeant)
6.3.3 Valeant: Revenue Forecast 2016-2026
6.3.3.1 Valeant: Ophthalmic Drugs Market Share Forecast 2016-2026
6.3.4 Valeant: SWOT Analysis
6.3.4.1 Valeant’s Acquisition of Bausch and Lomb: Aggressive Expansion?
6.3.4.2 Valeant: Difficult End to 2015 Puts Company Future in Doubt
7. Emerging Ophthalmic Drug Manufacturers in 2016
7.1 Companies with Small Ophthalmic Portfolios and Promising Pipeline Candidates, 2016
7.2 Acucela
7.3 Aerie Pharmaceuticals
7.4 Aerpio Therapeutics: Developing AKB 9778
7.5 Alimera Sciences
7.5.1 Iluvien: Increasing Geographical Reach and Increasing Sales
7.5.2 NADPH Oxidase Inhibitors Offer Potential for Dry AMD
7.6 Amakem
7.7 Ampio Pharmaceuticals
7.8 Chengdu Kanghong Pharmaceutical
7.9 Eleven Biotherapeutics
7.10 EyeGate Pharmaceuticals
7.11 Gene Signal
7.11.1 Aganirsen: Preventing Corneal Graft Rejection
7.12 Icon Bioscience
7.13 MacuCLEAR
7.13.1 MC 1101: a Potential Therapy for Dry AMD
7.14 Neurotech
7.15 Omeros
7.16 OphthaliX (Can-Fite BioPharma)
7.17 Ophthotech
7.17.1 Fovista: Potential Game-Changer in AMD
7.17.2 Fovista: Significant Improvement on Lucentis in Phase II Trials
7.17.3 Zimura: Complement C5 Inhibitor
7.18 Otsuka Pharmaceutical
7.19 pSivida Corp.
7.20 RXi Pharmaceuticals: Will Bevasiranib Resume Development?
7.21 Shire
7.21.1 Lifitegrast (SHP606) for Dry Eye
7.21.2 Premiplex (SHP607): Preventing Retinopathy of Prematurity
7.22 ThromboGenics
7.22.1 Jetrea (ocriplasmin)
7.22.2 ThromboGgenics: Leading Diabetic Eye Disease Pipeline
8. Qualitative Analysis of the Ophthalmic Drugs Market 2016-2026
8.1 Porter’s Five Forces Analysis of the Ophthalmic Drugs Market
8.1.1 Rivalry Among Competitors [Medium]
8.1.2 Threat of New Entrants [Low]
8.1.3 Power of Suppliers [Low]
8.1.4 Power of Buyers [Medium]
8.1.5 Threat of Substitutes [Medium]
9. Conclusions
9.1 Ophthalmic Pharmaceuticals: A Growing Niche Market
9.2 The World Ophthalmic Drugs Market in 2015
9.2.1 Leading Ophthalmic Drugs Market Segments
9.2.2 Leading Ophthalmic Drugs
9.2.3 Leading Ophthalmic Drugs Companies
9.3 World Ophthalmic Drugs Market Forecast 2016-2026
9.4 The Future of the Ophthalmic Drugs Market?
9.4.1 Increasing Revenue Concentration among Specialist Companies
9.4.2 The Rise of Generics
9.4.3 Small Companies Can Have a Big Impact
9.4.4 What Will Succeed in the Ophthalmic Drugs Market?
10. Glossary
【レポート販売概要】
■ タイトル:医薬品有力企業シリーズ: 眼薬メーカー上位25社分析2016-2026■ 英文:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2016-2026
■ 発行日:2016年5月
■ 調査会社:visiongain
■ 商品コード:VGAIN60620
■ 調査対象地域:グローバル
- 世界のコネクティッド健康M2Mサービス市場動向(2014-2018)TechNavio's analysts forecast the Global Connected Health M2M Services Market to grow at a CAGR of 30.08 percent over the period 2013-2018. One of the key factors contributing to this market growth is an increase in aging population. The Global Connected Health M2M Services Market has also been witnessing the increasing demand for remote healthcare monitoring. However, the low quality of wireless …
- 飲料パッケージングの世界市場2017-2021About Beverage Packaging Beverage packaging provides product support, external environment protection, and tampering resistance to beverages. Beverage packaging aids in reliable distribution of beverages among the value chain and reduces post production damage. Primary packaging is an important part of the marketing mix as it has a strong impact on the buying decision of the consumers. Technavio’s …
- ロボットカー/無人車の世界市場分析、セグメント予測The global autonomous cars market is expected to reach 138,089 units by 2024, according to a new study by Grand View Research, Inc. The growing acceptance of semi-autonomous technologies, such as Adaptive Cruise Control (ACC), automatic parking, and forward collision avoidance, is anticipated to pave the way for the adoption of driverless automobiles over the next seven years. An upsurge in the de …
- 収益サイクル管理(RCM)の世界市場分析:製品別、タイプ別(統合型、スタンドアロン)、送達モード別(オンプレミス、Webベース、クラウドベース)、エンドユーザー別(医師オフィス、病院、診断ラボ)、セグメント予測、2014-2025The global revenue cycle management (rcm) market is expected to reach USD 65.2 billion by 2025, according to a new report by Grand View Research, Inc. The healthcare system is witnessing a paradigm shift primarily due to the changing dynamics of the business models. These changing dynamics of the hospital industry in developed regions is expected to involve centralization and digitalization of the …
- ヘルスケア分析/医療分析の世界市場予測(~2022年)“Global healthcare analytics market projected to grow at a CAGR of 27.3%”The healthcare analytics market is expected to reach USD 29.84 billion by 2022 from USD 8.92 billion in 2017, at a CAGR of 27.3%. Increasing government initiatives to increase EHR adoption, growing pressure to curb healthcare costs, availability of big data in healthcare, increasing venture capital investments, rising focus o …
- Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Mobility Aids and Transportation Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Mobility Aids and Transportation Equipment market in the BRICS countries. The report provides …
- Double Eagle Petroleum Co.:石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Double Eagle Petroleum Co. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Double Eagle Petroleum Co. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- 乳製品加工装置の世界市場2016-2020About Dairy Processing Equipment The advent of processed dairy products has opened up new avenues such as off-farm jobs including collection, marketing, transportation, and processing. It is observed that in less developed countries, milk is directly sold to the public, and in milk manufacturing countries, it is sold on a wholesale basis.In developed countries, customers are more health conscious, …
- Pakistan Petroleum Limited:石油・ガスバリューチェーン分析レポート2013Pakistan Petroleum Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Pakistan Petroleum Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Pakistan Petroleum Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chai …
- 整形外科デバイス製造アウトソーシングの世界市場2016-2020About Outsourced Orthopedic Manufacturing An orthopedic implant is a device used in replacement procedures for the hip, spine, knee, and other extremities such as the shoulder, wrist, elbow, and ankle, or for supporting a damaged bone. Orthopedic devices are segmented into three types: implants, instruments, and cases and trays. The orthopedic devices market is highly competitive, and hence, many …
- 電力レンタル付属品の世界市場2017-2021About Power Rental Accessories Rental power is used to meet peak load demand, base load supply, or as a standby. The need to provide uninterrupted power is a major factor driving the growth of the global power rental accessories market. Power rentals are more economical than maintaining a reserve plant. Thus, this factor has increased the demand for rental power over time. Technavio’s analysts for …
- 不応性急性骨髄性白血病:グローバル臨床試験レビュー(2014年上半期)Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Refractory Acute Myeloid Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Acute Myeloid Leukemia. It i …
- ポリシリコンの世界市場分析:技術別、用途別(太陽光発電、電子)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東、アフリカ)、動向・動態、競争戦略、セグメント予測、2014-2025The global polysilicon market is anticipated to reach USD 13.56 billion by 2025, according to a new report by Grand View Research, Inc. The growing solar PV (photovoltaic) and electronic industry are expected to propel market demand over the coming years. The FBR technology used in the production of polysilicon has helped to reduce manufacturing cost to a large extent, thus lowering prices of poly …
- ナノファイバーの世界市場2016-2020About Nanofiber Nanofibers is a nano-object with the size of 1 billionth of a meter. The fibers are made through electrospinning, which is the most common and commercially used way of manufacturing nanofibers. Through this process, an electrified polymer solution is moved in a high voltage electric field to give elongated nanofibers. Many nanofibers are laid over one another to form a nano mat. A …
- ベータ2ミクログロブリン検査の世界市場2015The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technologi …